{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:22:55Z","timestamp":1763727775471,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08310","23K15227","24K19129","23K15226","21K16189","23K07717"],"award-info":[{"award-number":["22K08310","23K15227","24K19129","23K15226","21K16189","23K07717"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24gm1210009h0006, 23gm1210009h0005, 22gm1210009h0004"],"award-info":[{"award-number":["24gm1210009h0006, 23gm1210009h0005, 22gm1210009h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japanese Association of Dialysis Physicians and Foundation"},{"name":"Tsuchiya Memorial Medical Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25362-0","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:03:39Z","timestamp":1763726619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Finerenone ameliorates diabetic kidney disease exacerbated by deletion of natriuretic peptide\/guanylyl cyclase-A signaling and dietary high-protein load"],"prefix":"10.1038","volume":"15","author":[{"given":"Yui","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Sugioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akie","family":"Ikushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruomi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tokudome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"25362_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3 (2020).","journal-title":"Lancet"},{"key":"25362_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic, R. Z., Rooney, M. T. & Tuttle, K. R. Diabetic kidney disease: Challenges, progress, and possibilities. Clin. J. Am. Soc. Nephrol. 12, 2032\u20132045. https:\/\/doi.org\/10.2215\/CJN.11491116 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"25362_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle, K. R. et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 102, 248\u2013260. https:\/\/doi.org\/10.1016\/j.kint.2022.05.012 (2022).","journal-title":"Kidney Int."},{"key":"25362_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata, S., Nagase, M., Yoshida, S., Kawachi, H. & Fujita, T. Podocyte as the target for aldosterone: Roles of oxidative stress and Sgk1. Hypertension 49, 355\u2013364. https:\/\/doi.org\/10.1161\/01.HYP.0000255636.11931.a2 (2007).","journal-title":"Hypertension"},{"key":"25362_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown, N. J. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat. Rev. Nephrol. 9, 459\u2013469. https:\/\/doi.org\/10.1038\/nrneph.2013.110 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"25362_CR6","doi-asserted-by":"publisher","first-page":"F435","DOI":"10.1152\/ajprenal.00029.2022","volume":"323","author":"HS Jang","year":"2022","unstructured":"Jang, H. S. et al. Hepatic and proximal tubule angiotensinogen play distinct roles in kidney dysfunction, glomerular and tubular injury, and fibrosis progression. Am. J. Physiol. Renal Physiol. 323, F435\u2013F446. https:\/\/doi.org\/10.1152\/ajprenal.00029.2022 (2022).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"25362_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/bmj.38237.585000.7C","volume":"329","author":"GF Strippoli","year":"2004","unstructured":"Strippoli, G. F., Craig, M., Deeks, J. J., Schena, F. P. & Craig, J. C. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: Systematic review. BMJ 329, 828. https:\/\/doi.org\/10.1136\/bmj.38237.585000.7C (2004).","journal-title":"BMJ"},{"key":"25362_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/er.2005-0014","volume":"27","author":"LR Potter","year":"2006","unstructured":"Potter, L. R., Abbey-Hosch, S. & Dickey, D. M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47\u201372. https:\/\/doi.org\/10.1210\/er.2005-0014 (2006).","journal-title":"Endocr. Rev."},{"key":"25362_CR9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1681\/ASN.2011100985","volume":"23","author":"Y Ogawa","year":"2012","unstructured":"Ogawa, Y. et al. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J. Am. Soc. Nephrol. 23, 1198\u20131209. https:\/\/doi.org\/10.1681\/ASN.2011100985 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"25362_CR10","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3390\/nu15163503","volume":"15","author":"V Faerber","year":"2023","unstructured":"Faerber, V. et al. The microbiome and protein carbamylation: potential targets for protein-restricted diets supplemented with ketoanalogues in predialysis chronic kidney disease. Nutrients 15, 3503. https:\/\/doi.org\/10.3390\/nu15163503 (2023).","journal-title":"Nutrients"},{"key":"25362_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206134","volume":"13","author":"B Yan","year":"2018","unstructured":"Yan, B., Su, X., Xu, B., Qiao, X. & Wang, L. Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis. PLoS ONE 13, e0206134. https:\/\/doi.org\/10.1371\/journal.pone.0206134 (2018).","journal-title":"PLoS ONE"},{"key":"25362_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jcsm.12264","volume":"9","author":"CM Rhee","year":"2018","unstructured":"Rhee, C. M., Ahmadi, S. F., Kovesdy, C. P. & Kalantar-Zadeh, K. Low-protein diet for conservative management of chronic kidney disease: A systematic review and meta-analysis of controlled trials. J. Cachexia Sarcopenia Muscle 9, 235\u2013245. https:\/\/doi.org\/10.1002\/jcsm.12264 (2018).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"25362_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/nu10111744","volume":"10","author":"D Watanabe","year":"2018","unstructured":"Watanabe, D., Machida, S., Matsumoto, N., Shibagaki, Y. & Sakurada, T. Age modifies the association of dietary protein intake with all-cause mortality in patients with chronic kidney disease. Nutrients 10,\u00a01744.\u00a0https:\/\/doi.org\/10.3390\/nu10111744 (2018).","journal-title":"Nutrients"},{"issue":"3","key":"25362_CR14","doi-asserted-by":"publisher","first-page":"F763","DOI":"10.1152\/ajprenal.00484.2019","volume":"318","author":"A Bj\u00f6rnson Granqvist","year":"2020","unstructured":"Bj\u00f6rnson Granqvist, A. et al. High-protein diet accelerates diabetes and kidney disease in the BTBR ob\/ob mouse. Am. J. Physiol. Renal Physiol. 318(3), F763\u2013F771. https:\/\/doi.org\/10.1152\/ajprenal.00484.2019 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"25362_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172537","volume":"860","author":"SA N\u00f8rgaard","year":"2019","unstructured":"N\u00f8rgaard, S. A. et al. Nephropathy in diabetic db\/db mice is accelerated by high protein diet and improved by the SGLT2 inhibitor dapagliflozin. Eur. J. Pharmacol. 860, 172537. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172537 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"25362_CR16","doi-asserted-by":"publisher","first-page":"F979","DOI":"10.1152\/ajprenal.00076.2020","volume":"318","author":"M Zhan","year":"2020","unstructured":"Zhan, M. & Kanwar, Y. S. An enigma: Does a high-protein diet accelerate renal damage in humans? Lessons from diabetic animal models. Am. J. Physiol. Renal Physiol. 318, F979\u2013F981. https:\/\/doi.org\/10.1152\/ajprenal.00076.2020 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"25362_CR17","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1681\/ASN.2020010028","volume":"31","author":"GJ Ko","year":"2020","unstructured":"Ko, G. J., Rhee, C. M., Kalantar-Zadeh, K. & Joshi, S. The effects of high-protein diets on kidney health and longevity. J. Am. Soc. Nephrol. 31, 1667\u20131679. https:\/\/doi.org\/10.1681\/ASN.2020010028 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"25362_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2337\/diab.41.4.533","volume":"41","author":"N Perico","year":"1992","unstructured":"Perico, N. et al. Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 41, 533\u2013538. https:\/\/doi.org\/10.2337\/diab.41.4.533 (1992).","journal-title":"Diabetes"},{"key":"25362_CR19","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1681\/ASN.V481564","volume":"4","author":"PL Zhang","year":"1994","unstructured":"Zhang, P. L., Mackenzie, H. S., Troy, J. L. & Brenner, B. M. Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats. J. Am. Soc. Nephrol. 4, 1564\u20131570. https:\/\/doi.org\/10.1681\/ASN.V481564 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"25362_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148682","volume":"7","author":"DV Ilatovskaya","year":"2022","unstructured":"Ilatovskaya, D. V. et al. Effects of elevation of ANP and its deficiency on cardiorenal function. JCI Insight 7, e148682. https:\/\/doi.org\/10.1172\/jci.insight.148682 (2022).","journal-title":"JCI Insight"},{"key":"25362_CR21","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.25011\/cim.v35i5.18701","volume":"35","author":"CL Cheng","year":"2012","unstructured":"Cheng, C. L. et al. Advanced glycation end-products activate the renin-angiotensin system through the RAGE\/PI3-K signaling pathway in podocytes. Clin. Invest. Med. 35, E282. https:\/\/doi.org\/10.25011\/cim.v35i5.18701 (2012).","journal-title":"Clin. Invest. Med."},{"key":"25362_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.amjms.2018.10.008","volume":"357","author":"JM Garagliano","year":"2019","unstructured":"Garagliano, J. M. et al. Advanced glycation end products stimulate angiotensinogen production in renal proximal tubular cells. Am. J. Med. Sci. 357, 57\u201366. https:\/\/doi.org\/10.1016\/j.amjms.2018.10.008 (2019).","journal-title":"Am. J. Med. Sci."},{"key":"25362_CR23","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi, E. R. et al. Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 63, 1791\u20131800. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00929.x (2003).","journal-title":"Kidney Int."},{"key":"25362_CR24","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1038\/ki.1995.474","volume":"48","author":"D Ritter","year":"1995","unstructured":"Ritter, D., Dean, A. D., Gluck, S. L. & Greenwald, J. E. Natriuretic peptide receptors A and B have different cellular distributions in rat kidney. Kidney Int. 48, 5758\u20135766. https:\/\/doi.org\/10.1038\/ki.1995.474 (1995).","journal-title":"Kidney Int."},{"key":"25362_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00424-022-02774-9","volume":"475","author":"ES Heinl","year":"2023","unstructured":"Heinl, E. S. et al. Localization of natriuretic peptide receptors A, B, and C in healthy and diseased mouse kidneys. Pflugers Arch. 475, 343\u2013360. https:\/\/doi.org\/10.1007\/s00424-022-02774-9 (2023).","journal-title":"Pflugers Arch."},{"key":"25362_CR26","doi-asserted-by":"publisher","first-page":"46624","DOI":"10.1038\/srep46624","volume":"7","author":"Y Kato","year":"2017","unstructured":"Kato, Y. et al. Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition. Sci. Rep. 7, 46624. https:\/\/doi.org\/10.1038\/srep46624 (2017).","journal-title":"Sci. Rep."},{"key":"25362_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.108.045773","volume":"74","author":"R F\u00fcrst","year":"2008","unstructured":"F\u00fcrst, R. et al. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo. Mol. Pharmacol. 74, 1\u20138. https:\/\/doi.org\/10.1124\/mol.108.045773 (2008).","journal-title":"Mol. Pharmacol."},{"key":"25362_CR28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1172\/JCI37430","volume":"119","author":"M Kuhn","year":"2009","unstructured":"Kuhn, M. et al. The natriuretic peptide\/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice. J. Clin. Invest. 119, 2019\u20132030. https:\/\/doi.org\/10.1172\/JCI37430 (2009).","journal-title":"J. Clin. Invest."},{"key":"25362_CR29","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1172\/JCI23360","volume":"115","author":"K Sabrane","year":"2005","unstructured":"Sabrane, K. et al. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115, 1666\u20131674. https:\/\/doi.org\/10.1172\/JCI23360 (2005).","journal-title":"J Clin Invest"},{"key":"25362_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris, G. L. et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N. Engl. J. Med. 383, 2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845 (2020).","journal-title":"N. Engl. J. Med."},{"key":"25362_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","volume":"58","author":"NJ Brown","year":"2000","unstructured":"Brown, N. J. et al. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int. 58, 1219\u20131227. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00277.x (2000).","journal-title":"Kidney Int."},{"key":"25362_CR32","doi-asserted-by":"publisher","first-page":"F628","DOI":"10.1152\/ajprenal.00505.2020","volume":"320","author":"C Sierra-Ramos","year":"2021","unstructured":"Sierra-Ramos, C. et al. Increased SGK1 activity potentiates mineralocorticoid\/NaCl-induced kidney injury. Am. J. Physiol. Renal. Physiol. 320, F628\u2013F643. https:\/\/doi.org\/10.1152\/ajprenal.00505.2020 (2021).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"25362_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000368267","volume":"128","author":"F Artunc","year":"2014","unstructured":"Artunc, F. & Lang, F. Mineralocorticoid and SGK1-sensitive inflammation and tissue fibrosis. Nephron. Physiol. 128, 35\u201339. https:\/\/doi.org\/10.1159\/000368267 (2014).","journal-title":"Nephron. Physiol."},{"key":"25362_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/378065a0","volume":"378","author":"MJ Lopez","year":"1995","unstructured":"Lopez, M. J. et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378, 65\u201368. https:\/\/doi.org\/10.1038\/378065a0 (1995).","journal-title":"Nature"},{"key":"25362_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.1983.40","volume":"23","author":"JI Kreisberg","year":"1983","unstructured":"Kreisberg, J. I. & Karnovsky, M. J. Glomerular cells in culture. Kidney Int. 23, 439\u2013447. https:\/\/doi.org\/10.1038\/ki.1983.40 (1983).","journal-title":"Kidney Int."},{"key":"25362_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ki.1984.231","volume":"26","author":"PA Harper","year":"1984","unstructured":"Harper, P. A., Robinson, J. M., Hoover, R. L., Wright, T. C. & Karnovsky, M. J. Improved methods for culturing rat glomerular cells. Kidney Int. 26, 875\u2013880. https:\/\/doi.org\/10.1038\/ki.1984.231 (1984).","journal-title":"Kidney Int."},{"key":"25362_CR37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.kint.2023.08.010","volume":"104","author":"T Ishimura","year":"2023","unstructured":"Ishimura, T. et al. Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NF\u03ba\u0392 pathway inhibition. Kidney Int. 104, 929\u2013942. https:\/\/doi.org\/10.1016\/j.kint.2023.08.010 (2023).","journal-title":"Kidney Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25362-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:03:40Z","timestamp":1763726620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25362-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H. Yokoi has received Speakers Bureau from AstraZeneca and Kyowa Kirin Co. Ltd., and research grants from Chugai Pharmaceutical, Otsuka Pharmaceutical, and Kyowa Kirin Co. Ltd. All the other authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41378"}}